Epigenetics Diagnostics Market Analysis 2025-2034: Oncology Led with 68.7% Share in 2024, Driven by Demand for Early and Precise Cancer Detection Through Epigenetic Markers

The market, dominated by DNA methylation, sees significant contributions from North America, with the U.S. leading. Major players include Thermo Fisher Scientific, Illumina, and Roche Diagnostics, focusing on innovative tools that enhance precision medicine.

The market, dominated by DNA methylation, sees significant contributions from North America, with the U.S. leading. Major players include Thermo Fisher Scientific, Illumina, and Roche Diagnostics, focusing on innovative tools that enhance precision medicine.

Source: https://www.globenewswire.com/news-release/2025/06/17/3100406/28124/en/Epigenetics-Diagnostics-Market-Analysis-2025-2034-Oncology-Led-with-68-7-Share-in-2024-Driven-by-Demand-for-Early-and-Precise-Cancer-Detection-Through-Epigenetic-Markers.html